A team led by Prof. Wuran Wei from West China Hospital of Sichuan University and Dr. Dechao Feng from the Division of Surgery ...

The findings support further clinical investigations into mTOR-targeting drugs to assess their potential benefits in DN management. Genes & Diseases publishes rigorously peer-reviewed and high ...

A newly published study in Genes & Diseases highlights the crucial role of the mammalian target of rapamycin (mTOR) pathway ...

SHANNON, CLARE, IRELAND, February 25, 2025 /EINPresswire / -- A newly published study in Genes & Diseases highlights the crucial role of the mammalian target of rapamycin (mTOR) pathway in the ...

Innovations in therapeutic strategies, coupled with a deeper understanding of breast cancer biology, will be essential for advancing personalized ...

The review highlights how certain gene mutations and disrupted signaling ... One of the most disrupted pathways is PI3K/Akt/mTOR. It plays a central role in cell growth, but in many breast cancers ...

Genprex (GNPX) announced that its research collaborators will present at the upcoming 2025 American Association for Cancer Research, or AACR, ...

While Rheb mutations also result in mTOR pathway hyperactivation, TSC is predominately caused by mutations in the TSC2 or TSC2 genes, which are key regulators of the mTOR pathway. So, PTI-125’s ...